{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:49:02Z","timestamp":1777693742734,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMC"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.2174\/0929867054020981","type":"journal-article","created":{"date-parts":[[2005,5,28]],"date-time":"2005-05-28T04:46:47Z","timestamp":1117255607000},"page":"1283-1294","source":"Crossref","is-referenced-by-count":79,"title":["Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy"],"prefix":"10.2174","volume":"12","author":[{"given":"Nuno","family":"Cerqueira","sequence":"first","affiliation":[]},{"given":"Susana","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Ramos","sequence":"additional","affiliation":[]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/61250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T14:22:45Z","timestamp":1448029365000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=0929-8673&volume=12&issue=11&spage=1283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867054020981","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}